OncologyEducation is proud to present Dr. David Hogg discussing new treatment options and advances in Merkel cell carcinoma. 
This educational program will be offered as an interactive webinar.

Note: This program is for healthcare professionals only.


Learning Objectives:

  1. Address key issues and educational topics in Merkel cell carcinoma, with an emphasis on practical treatment and patient management approaches.

  2. Provide a comprehensive overview of Merkel cell carcinoma including diagnosis, epidemiology and pathology.

  3.  Discuss the multi-disciplinary approach to Merkel cell carcinoma and review best practices for medical, radiation and surgical oncologists, and dermatologists.

  4. Review trends and shifts in the treatment landscape of Merkel cell carcinoma, as well as, management of side effects and challenging cases.


Target Audience: 

Medical oncologists, radiation oncologists, surgical oncologists, dermatologists, pathologists and nurses treating skin cancer cancer patients. 


Webinar Presentation

Thursday, May 24, 2018 at 7PM EDT
Available across all time zones


About the Speaker: 

Dr Suresh Ramalingam

Dr. David Hogg is a Professor at the University of Toronto, and an attending physician at Princess Margaret Hospital. He leads the Medical Oncology Skin Cancer Site Group at PMH, and has been involved in numerous trials exploring both targeted and immunotherapies in melanoma. His interests also include the molecular genetics of inherited melanoma and other malignancies.


This program was made possible by EMD Serono and Pfizer.


Other Information

For more information, please send requests to  andrea@oncologyeducation.com.

Oncology Clinical News

Powered by OBR Oncology